HAP Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-225,000	Closed	-$711K	–	1248
2024 Q1	$711K	Buy	+225,000	New	+$15.5M	0.22%	154
2022 Q1	–	Sell	-14,100	Closed	-$174K	–	3769
2021 Q4	$174K	Buy	+14,100	New	+$592K	0.01%	1066
2021 Q1	–	Sell	-54,100	Closed	-$78K	–	3445
2020 Q4	$78K	Sell	54,100 -4,800	-8%	-$126K	0.01%	1268
2020 Q3	$144K	Sell	58,900 -581,200	-91%	-$13.3M	0.02%	725
2020 Q2	$1.32M	Buy	640,100 +627,200	+4,862%	+$12.7M	0.15%	230
2020 Q1	$32K	Sell	12,900 -624,200	-98%	-$13.6M	﹤0.01%	853
2019 Q4	$12.2M	Buy	637,100 +621,700	+4,037%	+$7.46M	0.91%	29
2019 Q3	$18K	Sell	15,400 -20,100	-57%	-$193K	﹤0.01%	961
2019 Q2	$120K	Buy	+35,500	New	+$455K	0.01%	576
2017 Q3	–	Sell	-31,000	Closed	-$3K	–	1343
2017 Q2	$3K	Sell	31,000 -900	-3%	-$10.4K	﹤0.01%	902
2017 Q1	$52K	Buy	+31,900	New	+$462K	﹤0.01%	677
2016 Q4	–	Sell	-31,800	Closed	-$14K	–	1591
2016 Q3	$14K	Buy	+31,800	New	+$1.29M	﹤0.01%	936